Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1606 AL 1620

Comparative study of the volume of the temporal lobe sections and neuropeptide effect in Alzheimer's patients and healthy persons

Petekkaya E, Burakgazi G, Kuş B, Melek İM, Arpacı A.

Int J Neurosci. 2021 Aug;131(8):725-734. doi: 10.1080/00207454.2020.1831490. Epub 2020 Oct 16.

Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models

Cenini G, Hebisch M, Iefremova V, Flitsch LJ, Breitkreuz Y, Tanzi RE, Kim DY, Peitz M, Brüstle O.

Mol Cell Neurosci. 2021 Jan;110:103568. doi: 10.1016/j.mcn.2020.103568. Epub 2020 Oct 14.

Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease

Arnsten AFT, Datta D, Del Tredici K, Braak H.

Alzheimers Dement. 2021 Jan;17(1):115-124. doi: 10.1002/alz.12192. Epub 2020 Oct 19.

The structure and phase of tau: from monomer to amyloid filament

Zeng Y, Yang J, Zhang B, Gao M, Su Z, Huang Y.

Cell Mol Life Sci. 2021 Mar;78(5):1873-1886. doi: 10.1007/s00018-020-03681-x. Epub 2020 Oct 19.

Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease

Rahman MA, Islam K, Rahman S, Alamin M.

Mol Neurobiol. 2021 Mar;58(3):1017-1023. doi: 10.1007/s12035-020-02177-w. Epub 2020 Oct 19.

Physical exercise protocols in animal models of Alzheimer's disease: a systematic review

De Sousa RAL, Rodrigues CM, Mendes BF, Improta-Caria AC, Peixoto MFD, Cassilhas RC.

Metab Brain Dis. 2021 Jan;36(1):85-95. doi: 10.1007/s11011-020-00633-z. Epub 2020 Oct 23.

Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism

Xing S, Li Q, Xiong B, Chen Y, Feng F, Liu W, Sun H.

Med Res Rev. 2021 Mar;41(2):858-901. doi: 10.1002/med.21745. Epub 2020 Oct 25.

Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

Sun BL, Chen Y, Fan DY, Zhu C, Zeng F, Wang YJ.

Sci China Life Sci. 2021 Jun;64(6):926-937. doi: 10.1007/s11427-020-1810-y. Epub 2020 Oct 23.

Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease

Gleason A, Bush AI.

Neurotherapeutics. 2021 Jan;18(1):252-264. doi: 10.1007/s13311-020-00954-y. Epub 2020 Oct 27.

Are Medical Care Expenses Higher for Spouses Who Provide Dementia Care?

Albert SM.

Am J Geriatr Psychiatry. 2021 May;29(5):476-477. doi: 10.1016/j.jagp.2020.10.008. Epub 2020 Oct 21.

Sex and gender differences in cognitive and brain reserve: Implications for Alzheimer's disease in women

Subramaniapillai S, Almey A, Natasha Rajah M, Einstein G.

Front Neuroendocrinol. 2021 Jan;60:100879. doi: 10.1016/j.yfrne.2020.100879. Epub 2020 Nov 1.

Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance

Wang L, Bharti, Kumar R, Pavlov PF, Winblad B.

Eur J Med Chem. 2021 Jan 1;209:112915. doi: 10.1016/j.ejmech.2020.112915. Epub 2020 Oct 15.

Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy

Zhang W, Feng C, Jiang H.

Ageing Res Rev. 2021 Jan;65:101207. doi: 10.1016/j.arr.2020.101207. Epub 2020 Nov 1.

Dynamic brain fluctuations outperform connectivity measures and mirror pathophysiological profiles across dementia subtypes: A multicenter study

Moguilner S, García AM, Perl YS, Tagliazucchi E, Piguet O, Kumfor F, Reyes P, Matallana D, Sedeño L, Ibáñez A.

Neuroimage. 2021 Jan 15;225:117522. doi: 10.1016/j.neuroimage.2020.117522. Epub 2020 Nov 2.

Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria

John A, Reddy PH.

Ageing Res Rev. 2021 Jan;65:101208. doi: 10.1016/j.arr.2020.101208. Epub 2020 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias